心理激励联合艾司西酞普兰干预对慢性阻塞性肺疾病伴焦虑患者心理状态的影响  

Effect of psychological stimulation combined with escitalopram on psychological status of patients with chronic obstructive pulmonary disease and anxiety

作　　者：曾菊蓉 谢晓红[1] 蒋慧[1] 刘丽[1] 刘恋 查蕾 ZENG Jurong;XIE Xiaohong;JIANG Hui;LIU Li;LIU Lian;ZHA Lei(Department of Respiratory Medicine,Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072,China;Department of Critical Care Medicine,Sichuan Academy of Medical Sciences,Sichuan Provincial People's Hospital)

机构地区：[1]成都中医药大学附属医院呼吸内科,610072 [2]四川省医学科学院,四川省人民医院重症医学科

出　　处：《中国健康心理学杂志》2023年第2期186-191,共6页China Journal of Health Psychology

基　　金：四川省科技厅计划项目(编号:2020YFS0386);四川省干部保健科研课题(编号:川干研2019-513)。

摘　　要：目的:探究心理激励联合艾司西酞普兰干预对慢性阻塞性肺疾病(COPD)伴焦虑患者的影响。方法:选取2020年1月-2021年1月某院收治的120例COPD伴焦虑患者为研究对象,随机分为对照组和观察组,各60例,对照组给予常规干预和艾司西酞普兰,观察组在以上基础给予心理激励。比较心理状态[焦虑自评表(SAS)和抑郁自评表(SDS)]、肺功能[一秒用力呼气容积(FEV1)、第一秒用力呼气容积与用力肺活量比值(FEV1/FVC)]、自我效能[COPD自我效能量表(CSES)]、睡眠质量[匹兹堡睡眠质量指数(PSQI)]、总体幸福感[总体幸福感量表(GWB)]及生活质量[圣乔治呼吸问卷(SGRQ)]。结果:干预后,观察组SAS评分和SDS评分明显低于对照组(t=4.922,5.753;P<0.05),FEV1和FEV1/FVC明显高于对照组(t=5.227,6.308;P<0.05),CSES各维度评分明显高于对照组(t=6.351,4.124,5.554,6.330,7.317;P<0.05),GWB评分明显高于对照组(t=2.458,P<0.05),SGRQ各维度评分明显低于对照组(t=3.532,2.370,5.548;P<0.05)。结论:在艾司西酞普兰治疗的基础上给予COPD伴焦虑患者心理激励,可有效改善心理状态和肺功能,增强自我效能,提高睡眠质量和总体幸福感,提升生活质量。Objective:To explore the effect of psychological stimulation combined with escitalopram on chronic obstructive pulmonary disease(COPD)patients with anxiety.Methods:A total of 120 patients with COPD and anxiety treated in our hospital from January 2020 to January 2021 were selected as the research object, and randomly divided into control group and observation group, 60 cases in each group, the control group was given routine intervention and escitalopram, the observation group was given psychological incentive on the basis of the above.Psychological status[Self-rating Anxiety Scale(SAS)and self-rating depression Scale(SDS)],lung function[forced expiratory volume in one second(FEV1),ratio of forced expiratory volume in one second to forced vital capacity(FEV1/FVC)],self-efficacy[COPD self-efficacy Scale(CSES)],sleep quality[Pittsburgh Sleep Quality Index(PSQI)),general well-being[GWB]and Quality of life[St George’s Respiratory Questionnaire(SGRQ)].Results:After intervention, SAS score and SDS score of observation group were significantly lower than that in control group(t=4.922,5.753;P<0.05),FEV1 and FEV1/FVC were significantly higher than that in control group(t=5.227,6.308;P<0.05).CSES score was significantly higher than that in control group(t=6.351,4.124,5.554,6.330,7.317;P<0.05),GWB score was significantly higher than that in control group(t=2.458,P<0.05).The score of SGRQ was significantly lower than that of the control group(t=3.532,2.370,5.548;P<0.05).Conclusion:Psychological stimulation in COPD patients with anxiety based on escitalopram treatment can effectively improve mental state and lung function, enhance self-efficacy, improve sleep quality and overall well-being, and improve quality of life.

关 键 词：心理激励 艾司西酞普兰 慢性阻塞性肺疾病 焦虑 心理状态 

分 类 号：R749.92[医药卫生—神经病学与精神病学]